SLNO
Soleno Therapeutics Inc

8,146
Mkt Cap
$2.54B
Volume
1.43M
52W High
$90.32
52W Low
$41.50
PE Ratio
-26.83
SLNO Fundamentals
Price
$49.42
Prev Close
$47.35
Open
$47.27
50D MA
$60.27
Beta
0.76
Avg. Volume
1.39M
EPS (Annual)
-$4.38
P/B
5.36
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
HC Wainwright Has Bullish Forecast for SLNO FY2025 Earnings
Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) - Research analysts at HC Wainwright lifted their FY2025 EPS estimates for shares of Soleno Therapeutics in a report released on Monday, November...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Nan Fung Trinity HK Ltd. Invests $8.63 Million in Soleno Therapeutics, Inc. $SLNO
Nan Fung Trinity HK Ltd. acquired a new stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) in the second quarter, according to the company in its most recent 13F filing with the...
MarketBeat·2d ago
News Placeholder
Soleno Therapeutics (NASDAQ:SLNO) Shares Gap Up - Here's Why
Soleno Therapeutics (NASDAQ:SLNO) Shares Gap Up - Time to Buy...
MarketBeat·3d ago
News Placeholder
SLNO INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Launches Investigation into Soleno Therapeutics, Inc., and Encourages Investors and Potential Witnesses to Contact Law Firm
The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Soleno Therapeutics, Inc. (NASDAQ: SLNO) focused on whether Soleno and...
Business Wire·4d ago
News Placeholder
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Given Average Recommendation of "Moderate Buy" by Brokerages
Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Get Free Report) have been assigned an average rating of "Moderate Buy" from the fourteen research firms that are currently covering the company...
MarketBeat·4d ago
News Placeholder
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Soleno Therapeutics, Inc. (NASDAQ: SLNO) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Soleno Therapeutics, Inc. (NASDAQ: SLNO) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information...
PR Newswire·5d ago
News Placeholder
Soleno Therapeutics, Inc. $SLNO Shares Sold by Y Intercept Hong Kong Ltd
Y Intercept Hong Kong Ltd lowered its stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 86.2% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned...
MarketBeat·7d ago
News Placeholder
Soleno Therapeutics (NASDAQ:SLNO) Rating Increased to Buy at Wall Street Zen
Wall Street Zen raised Soleno Therapeutics from a "hold" rating to a "buy" rating in a report on Saturday...
MarketBeat·7d ago
News Placeholder
SLNO INVESTIGATION ALERT: Investigation Launched into Soleno Therapeutics, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm
SLNO INVESTIGATION ALERT: Investigation Launched into Soleno Therapeutics, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm SLNO INVESTIGATION ALERT: Investigation...
PR Newswire·7d ago
News Placeholder
Soleno Therapeutics (SLNO) Faces Investor Scrutiny Amid Disappointing VYKAT XR Starts, Discontinuations; Shares Down 26% -- Hagens Berman
Soleno Therapeutics (SLNO) Faces Investor Scrutiny Amid Disappointing VYKAT XR Starts, Discontinuations; Shares Down 26% -- Hagens Berman Soleno Therapeutics (SLNO) Faces Investor Scrutiny Amid...
PR Newswire·8d ago

Latest SLNO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.